Table 3. Clinical outcomes in the PD patients stratified according to HS-CRP levels.
Total | Lower tertile | Middle tertile | Upper tertile | ||
(n = 402) | (n = 134) | (n = 134) | (n = 134) | ||
HS-CRP (mg/L) | 9.57±16.35 | 0.90±0.43 | 3.90±1.69 | 23.90±22.09 | P |
(<1.77) | (1.77–7.51) | (>7.51) | |||
Outcomes | |||||
Death | 28 (7.0%) | 0 (0.0%) | 4 (3.0%) | 24 (17.9%) | <0.001 |
Transfer to HD | 81 (20.1%) | 25 (18.7%) | 25 (18.7%) | 31 (23.1%) | 0.575 |
Transplantation | 10 (2.5%) | 3 (2.2%) | 4 (3.0%) | 3 (2.2%) | 0.903 |
Technique survival | 283 (70.4%) | 106 (79.1%) | 101 (75.4%) | 76 (56.7%) | <0.001 |
Infection episodes | 192 (47.8%) | 55 (41.0%) | 66 (49.3%) | 71 (53.0%) | 0.14 |
Cardiovascular events | 72 (17.9%) | 17 (12.7%) | 21 (15.7%) | 34 (25.4%) | 0.02 |
Note:
Continuous variables given as mean ± standard deviation, and categorical variables, as number (percentage).
Abbreviations: PD, peritoneal dialysis; HS-CRP, high-sensitivity C-reactive protein; HD, hemodialysis.